Pluvicto & Metastatic Prostate Cancer

Target Your Cancer, Protect Your Health with Pluvicto Therapy
Request An Appointment

Pluvicto: A Game-Changer in Metastatic Prostate Cancer Treatment

Pluvicto® is setting a new standard for metastatic prostate cancer care, delivering targeted radiation directly to cancer cells. As one of the few centers nationwide offering this innovative therapy, United Theranostics is dedicated to providing patients with advanced, precision care. Here’s how Pluvicto stands above other treatment options:

Pluvicto: The Future of Prostate Cancer Treatment

Precision Targeting

Delivers radiation directly to PSMA-positive cancer cells, sparing healthy tissue.

Improved Survival

38% improvement in overall survival and 60% reduced risk of progression.

Personalized Care

Combines PSMA PET imaging with therapy for tailored, effective treatment.

Metastic Prostate Cancer

Metastatic prostate cancer occurs when cancer spreads beyond the prostate to areas like the bones or lymph nodes, making treatment options feel limited. That’s where Pluvicto®, a treatment offered by United Theranostics, can help. This advanced radiopharmaceutical therapy targets cancer cells directly, giving you or your loved one the chance for better outcomes and an improved quality of life.

If you’ve been diagnosed with metastatic prostate cancer, we’re here for you. Visit us at one of our outpatient procedure centers to explore cutting-edge care and compassionate support every step of the way. Schedule your consultation today.

Contact us now to take the first step toward advanced treatment.

Targeted Therapy, Real Results: The Benefits of Pluvicto

B
C

Targeted Treatment

Delivers radiation directly to PSMA-positive cancer cells while minimizing damage to healthy tissue.
B
C

Proven Results

Demonstrated improved overall survival and progression-free survival in clinical trials.
B
C

Fewer Systemic Side Effects

Compared to traditional chemotherapy, Pluvicto is less likely to cause widespread side effects.
B
C

Outpatient Convenience

Administered in a comfortable outpatient setting with minimal disruption to daily life.
B
C

Precision Medicine

Tailored to patients with PSMA-positive cancer for optimal effectiveness.
B
C

Multi-Session Therapy

Offers multiple doses for sustained treatment impact over time.

Getting Started with Pluvicto Treatment at United Theranostics

The process to begin Pluvicto treatment at United Theranostics is designed to provide you with personalized and effective care. Here’s how it works:

  1. Consultation and Evaluation:
    Schedule an initial consultation at our Princeton, NJ, Chesapeake, MD, or Las Cruces, NM, locations. Our expert team will review your medical history and discuss your previous treatments to determine if Pluvicto is the right option for you.
  2. PSMA PET Imaging:
    A PSMA PET scan is required to confirm that your cancer is PSMA-positive. This diagnostic step ensures that Pluvicto’s targeted therapy is appropriate and effective for your condition.
  3. Customized Care Plan:
    Based on your diagnosis and imaging results, we’ll develop a personalized care plan that outlines your Pluvicto infusion schedule and monitoring requirements.
  4. Insurance Verification and Support:
    Our team will work with your insurance provider to verify coverage and assist with pre-authorization. We also explore financial assistance programs for eligible patients.
  5. Start Treatment:
    Pluvicto is administered as an outpatient IV infusion every six weeks for up to six cycles. Each session is conducted in our comfortable, patient-focused setting, with regular monitoring to ensure safety and effectiveness.
  6. Follow-Up Care:
    Throughout your treatment, we will perform regular tests and imaging to track progress, adjust the plan as needed, and ensure the best possible outcomes.

If you’re ready to take the next step, contact United Theranostics to schedule your consultation today. Let us guide you through this innovative treatment journey with care and expertise.

Request An Appointment

Is Pluvicto the Right Treatment for You? Discover Your Next Step in Advanced Cancer Care

Pluvicto® offers hope for patients with metastatic castration-resistant prostate cancer (mCRPC) by delivering targeted radiation to PSMA-positive cancer cells. It’s designed for individuals who have already explored other therapies and are seeking an innovative option to manage their cancer effectively.

You may be a candidate for Pluvicto if:

  • You have metastatic castration-resistant prostate cancer (mCRPC).
  • Your cancer expresses PSMA, confirmed by a PSMA PET scan.
  • You’ve undergone androgen receptor pathway inhibitors.

Contact United Theranostics today to see if Pluvicto is the right choice for your advanced cancer care.

Request An Appointment

Revolutionizing Cancer Treatment with United Theranostics

Pluvicto® is transforming the way metastatic prostate cancer is treated, and United Theranostics is proud to be one of the few centers nationwide offering this advanced radiopharmaceutical therapy. We combine cutting-edge technology, expert care, and a compassionate approach to deliver precision-targeted treatments in a comfortable outpatient setting. From consultation to follow-up, our team guides you every step of the way.

  • Advanced Pluvicto therapy for metastatic prostate cancer
  • One of the few nationwide providers specializing in theranostics
  • Convenient locations in Princeton, NJ, Chesapeake, MD, or Las Cruces, NM.
  • State-of-the-art imaging and precision-targeted treatment
  • Personalized, patient-first care
Visit Us at one of our locations nearest you!

Frequently Asked Questions

Pluvicto® Treatments at United Theranostics

B
C

Am I eligible for Pluvicto treatment?

Pluvicto is specifically for patients with advanced prostate cancer who meet the following criteria:

  • Diagnosed with PSMA-positive mCRPC (confirmed via a PSMA PET scan).
  • Previously treated with androgen receptor pathway inhibitors.

Our team will work closely with you and your referring physician to evaluate your eligibility. We are committed to guiding you through every step of this journey, ensuring clarity and confidence in your treatment plan.

B
C

How does Pluvicto work on my cancer?

Pluvicto combines a radioactive particle, Lutetium-177, with a PSMA-targeting molecule. The therapy seeks out PSMA proteins in prostate cancer cells, delivering a highly localized dose of radiation that damages the DNA within these cells. This approach minimizes harm to surrounding healthy tissue, offering a more precise and effective treatment option.

B
C

What side effects should I be aware of?

Like any cancer therapy, Pluvicto may cause side effects. The most commonly reported include:

  • Fatigue or decreased energy.
  • Nausea or dry mouth.
  • Mild to moderate changes in blood counts (e.g., anemia).
  • Reduced appetite or constipation.

Our medical team is here to help you manage these symptoms effectively. We will proactively monitor your health throughout treatment and adjust your care plan as needed.

B
C

How can I protect my family and caregivers during treatment?

Because Pluvicto involves radiation, small amounts may pass through bodily fluids (e.g., urine or saliva). To minimize exposure to loved ones:

  • Practice good hygiene, such as washing hands thoroughly and frequently.
  • Avoid close contact with pregnant women or young children for a few days post-treatment.
  • Follow specific safety guidelines provided by our team.

At United Theranostics, we prioritize education and safety to ensure you and your family feel informed and at ease.

B
C

How will my progress be tracked during Pluvicto therapy?

We believe in precision care at every step. During your treatment, we’ll:

  • Perform regular blood tests to monitor kidney function, blood counts, and overall health.
  • Use advanced imaging (like PSMA PET scans) to assess the therapy’s effectiveness.
  • Hold frequent consultations to review your progress and address any concerns.

This collaborative approach ensures your treatment remains on track and caters to your body and cancer’s needs.

B
C

How do I get started with Pluvicto treatment?


Getting started is simple. You can:

  • Contact United Theranostics directly to schedule a consultation.
  • Request a referral from your oncologist or primary care physician.

During your consultation, we’ll review your medical history, confirm your PSMA-positive status with a PET scan, and design a treatment plan tailored to your needs.

B
C

HDoes insurance cover Pluvicto?


Coverage for Pluvicto varies depending on your insurance provider. At United Theranostics, we have a dedicated team to:

  • Verify your insurance benefits.
  • Assist with pre-authorizations.
  • Explore financial assistance programs for eligible patients.

We are committed to making this life-changing therapy accessible to everyone who needs it.

Aftercare FAQs for Pluvicto® Treatment

B
C

How can I minimize radiation exposure to others after treatment?

To keep your loved ones safe, avoid close contact (less than 3 feet) with others for the first two days after treatment. Avoid contact with children and pregnant individuals for seven days. Additionally, it’s recommended to sleep in a separate room from others for at least three days and up to 15 days if your household includes pregnant individuals.
B
C

Should I follow any specific dietary guidelines after Pluvicto® treatment?

Staying hydrated is key after Pluvicto. Drinking plenty of water helps your body eliminate any residual radioactivity through urine. Frequent urination during the first 24 hours after treatment is encouraged to support this process.
B
C

What side effects should I monitor after treatment?

Common side effects include fatigue, dry mouth, nausea, or changes in appetite. You may also notice mild changes in bowel movements or low blood counts. Contact your healthcare provider if you experience severe or prolonged symptoms; they can help manage any concerns.
B
C

When can I return to normal activities?

Most patients can resume regular activities within a few days. Your healthcare team will provide specific instructions based on your health and treatment, but taking it easy during the first few days can help you recover.
Visit Us at one of our locations nearest you!

Case Studies

A Patient with Advanced Metastatic Prostate Cancer

Read More

Targeted PSMA Therapy in an 85-Year-Old Male with mCRPC and BRCA Mutation

Read More